Atlas Trials

Lung Non-Small Cell Squamous Carcinoma

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lung Non-Small Cell Squamous Carcinoma

RecordFirmDate
Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer (NCT04216316)National Cancer Institute (NCI)2021-04-14
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) (NCT04267848)National Cancer Institute (NCI)2020-06-16
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296)SWOG Cancer Research Network2019-04-16
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer (NCT03110978)M.D. Anderson Cancer Center2017-06-26

Track Lung Non-Small Cell Squamous Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.